Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching
Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, b...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1996-05, Vol.39 (10), p.2047-2054 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2054 |
---|---|
container_issue | 10 |
container_start_page | 2047 |
container_title | Journal of medicinal chemistry |
container_volume | 39 |
creator | Wang, Shaomeng Milne, G. W. A Yan, Xinjian Posey, Isadora J Nicklaus, Marc C Graham, Lisa Rice, William G |
description | Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques. |
doi_str_mv | 10.1021/jm950874+ |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78049778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17028267</sourcerecordid><originalsourceid>FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</originalsourceid><addsrcrecordid>eNqFkEFv0zAUxy3ENErZgQ-AlANCSCzs2U7i5IjKxqpVEKllh12sZ9emKUlc7HSi336eWroDh52epf9Pf7_3I-Qthc8UGL1Yd1UOpcg-vSAjmjNIsxKyl2QEwFjKCsZfkdchrAGAU8ZPyWlZZCwv-IgsvjZBu3vjd4mzyff4as_j6NPabIZmaZLr6W1Kk9q7wWAwybRfNaoZnA-J2iX1Cn2H2m1WzptkbtDrVdP_ekNOLLbBnB3mmPy8ulxMrtPZj2_TyZdZihnkQ0ptoYxCiktlUVVQsQwrtMpSZrTgNss52go58NLqIs9LDpappQZU3FKKfEw-7Hs33v3ZmjDILl5j2hZ747ZBimihEqJ8FqQCWMkKEcGPe1B7F4I3Vm5806HfSQryUbX8pzqi7w6dW9WZ5RE8qI35-0OOQWNrPfa6CUeMQxl_LCKW7rEmDObvMUb_W8Z9RC4X9VxOxM0c7uqZzJ5qUQe5dlvfR8P_b_cAUi2f4g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17028267</pqid></control><display><type>article</type><title>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Wang, Shaomeng ; Milne, G. W. A ; Yan, Xinjian ; Posey, Isadora J ; Nicklaus, Marc C ; Graham, Lisa ; Rice, William G</creator><creatorcontrib>Wang, Shaomeng ; Milne, G. W. A ; Yan, Xinjian ; Posey, Isadora J ; Nicklaus, Marc C ; Graham, Lisa ; Rice, William G</creatorcontrib><description>Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm950874+</identifier><identifier>PMID: 8642563</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>AIDS/HIV ; Amino Acid Sequence ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Binding Sites ; Biological and medical sciences ; Cell Line ; Crystallography, X-Ray ; HIV Protease Inhibitors - chemistry ; HIV Protease Inhibitors - metabolism ; HIV Protease Inhibitors - pharmacology ; HIV-1 - drug effects ; human immunodeficiency virus 1 ; Humans ; Information Systems ; Medical sciences ; Models, Molecular ; Molecular Sequence Data ; Pharmacology. Drug treatments</subject><ispartof>Journal of medicinal chemistry, 1996-05, Vol.39 (10), p.2047-2054</ispartof><rights>Copyright © 1996 American Chemical Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</citedby><cites>FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm950874+$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm950874+$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3088266$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8642563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Shaomeng</creatorcontrib><creatorcontrib>Milne, G. W. A</creatorcontrib><creatorcontrib>Yan, Xinjian</creatorcontrib><creatorcontrib>Posey, Isadora J</creatorcontrib><creatorcontrib>Nicklaus, Marc C</creatorcontrib><creatorcontrib>Graham, Lisa</creatorcontrib><creatorcontrib>Rice, William G</creatorcontrib><title>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.</description><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Crystallography, X-Ray</subject><subject>HIV Protease Inhibitors - chemistry</subject><subject>HIV Protease Inhibitors - metabolism</subject><subject>HIV Protease Inhibitors - pharmacology</subject><subject>HIV-1 - drug effects</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Information Systems</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Pharmacology. Drug treatments</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFv0zAUxy3ENErZgQ-AlANCSCzs2U7i5IjKxqpVEKllh12sZ9emKUlc7HSi336eWroDh52epf9Pf7_3I-Qthc8UGL1Yd1UOpcg-vSAjmjNIsxKyl2QEwFjKCsZfkdchrAGAU8ZPyWlZZCwv-IgsvjZBu3vjd4mzyff4as_j6NPabIZmaZLr6W1Kk9q7wWAwybRfNaoZnA-J2iX1Cn2H2m1WzptkbtDrVdP_ekNOLLbBnB3mmPy8ulxMrtPZj2_TyZdZihnkQ0ptoYxCiktlUVVQsQwrtMpSZrTgNss52go58NLqIs9LDpappQZU3FKKfEw-7Hs33v3ZmjDILl5j2hZ747ZBimihEqJ8FqQCWMkKEcGPe1B7F4I3Vm5806HfSQryUbX8pzqi7w6dW9WZ5RE8qI35-0OOQWNrPfa6CUeMQxl_LCKW7rEmDObvMUb_W8Z9RC4X9VxOxM0c7uqZzJ5qUQe5dlvfR8P_b_cAUi2f4g</recordid><startdate>19960510</startdate><enddate>19960510</enddate><creator>Wang, Shaomeng</creator><creator>Milne, G. W. A</creator><creator>Yan, Xinjian</creator><creator>Posey, Isadora J</creator><creator>Nicklaus, Marc C</creator><creator>Graham, Lisa</creator><creator>Rice, William G</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19960510</creationdate><title>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</title><author>Wang, Shaomeng ; Milne, G. W. A ; Yan, Xinjian ; Posey, Isadora J ; Nicklaus, Marc C ; Graham, Lisa ; Rice, William G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a405t-1f6beba1adbfab90924a9afbf12ec73f453af9a3038fc655830f2bdc0ab3f11a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Crystallography, X-Ray</topic><topic>HIV Protease Inhibitors - chemistry</topic><topic>HIV Protease Inhibitors - metabolism</topic><topic>HIV Protease Inhibitors - pharmacology</topic><topic>HIV-1 - drug effects</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Information Systems</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Shaomeng</creatorcontrib><creatorcontrib>Milne, G. W. A</creatorcontrib><creatorcontrib>Yan, Xinjian</creatorcontrib><creatorcontrib>Posey, Isadora J</creatorcontrib><creatorcontrib>Nicklaus, Marc C</creatorcontrib><creatorcontrib>Graham, Lisa</creatorcontrib><creatorcontrib>Rice, William G</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Shaomeng</au><au>Milne, G. W. A</au><au>Yan, Xinjian</au><au>Posey, Isadora J</au><au>Nicklaus, Marc C</au><au>Graham, Lisa</au><au>Rice, William G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1996-05-10</date><risdate>1996</risdate><volume>39</volume><issue>10</issue><spage>2047</spage><epage>2054</epage><pages>2047-2054</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Fifteen novel non-peptide HIV-1 protease inhibitors were identified by flexible 3D database pharmacophore searching of the NCI DIS 3D database. The pharmacophore query used in the search was derived directly from the X-ray determined structures of protease/inhibitor complexes. These 15 inhibitors, belonging to nine different chemical classes, are promising leads for further development. The two best inhibitors found, NSC 32180, a “dimer” of 4-hydroxycoumarin, and NSC 117027, a “tetramer” of 2-hydroxy quinone, had ID50 values of 0.32 and 0.75 μM for HIV-1 protease inhibition, respectively, and two other inhibitors had ID50 values close to 1 μM. Among the potent inhibitors, NSC 158393 not only demonstrated activity against HIV-1 protease (ID50 1.7 μM) but also exhibited promising antiviral activity in HIV-1-infected CEM-SS cells (EC50 = 11.5 μM). Validation of the pharmacophore used in the search was accomplished by conformational analysis. The binding modes of the most potent inhibitor found in our studies, NSC 32180, were predicted employing docking and molecular dynamics techniques.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8642563</pmid><doi>10.1021/jm950874+</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1996-05, Vol.39 (10), p.2047-2054 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_78049778 |
source | MEDLINE; American Chemical Society Journals |
subjects | AIDS/HIV Amino Acid Sequence Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Binding Sites Biological and medical sciences Cell Line Crystallography, X-Ray HIV Protease Inhibitors - chemistry HIV Protease Inhibitors - metabolism HIV Protease Inhibitors - pharmacology HIV-1 - drug effects human immunodeficiency virus 1 Humans Information Systems Medical sciences Models, Molecular Molecular Sequence Data Pharmacology. Drug treatments |
title | Discovery of Novel, Non-Peptide HIV-1 Protease Inhibitors by Pharmacophore Searching |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T07%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20Novel,%20Non-Peptide%20HIV-1%20Protease%20Inhibitors%20by%20Pharmacophore%20Searching&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Wang,%20Shaomeng&rft.date=1996-05-10&rft.volume=39&rft.issue=10&rft.spage=2047&rft.epage=2054&rft.pages=2047-2054&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm950874+&rft_dat=%3Cproquest_cross%3E17028267%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17028267&rft_id=info:pmid/8642563&rfr_iscdi=true |